ArticleBlood advances2024
Al Tabaa Y, Casasnovas RO, Baillet C, et al. Prospective evaluation of lymphoma response to immunomodulatory therapy criteria in GATA trial from the LYSA group. Blood Adv. 2023;7(14):3735-3738.
PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.